LexinFintech Holdings Ltd. to Provide Business Update on September 16, 2020
SHENZHEN, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading online […]
HL Acquisitions Corp provides update on Business Combination with Fusion Fuel Green Ltd.
New York, NY, Sept. 14, 2020 (GLOBE NEWSWIRE) — HL Acquisitions Corp. (“HL”, NASDAQ: HCCH, HCCHU, HCCHR, HCCHW) announced today […]
SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
STAMFORD, Conn., Sept. 14, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing […]
Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder
Rapid, durable, and statistically significant improvement demonstrated in patient-reported depressive symptoms, as measured by the QIDS-SR-16 total score compared to […]
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platform
SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced it has entered into […]
Ruhnn Announces First Quarter of Fiscal Year 2021 Unaudited Financial Results
HANGZHOU, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — Ruhnn Holding Limited (“ruhnn” or the “Company”) (NASDAQ: RUHN), a leading internet […]
Celyad Oncology Establishes At-the-Market Facility
MONT-SAINT-GUIBERT, Belgium, Sept. 14, 2020 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused […]
89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH
SAN FRANCISCO, Sept. 13, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB) today announced that the company plans to share […]
NVIDIA to Acquire Arm for $40 Billion, Creating World’s Premier Computing Company for the Age of AI
Unites NVIDIA’s leadership in artificial intelligence with Arm’s vast computing ecosystem to drive innovation for all customersNVIDIA will expand Arm’s […]
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) — NEW YORK and MAINZ, GERMANY, September 12 — Pfizer Inc. […]
